Market is being manipulated higher as big money is pulling out ahead of a looming huge crash. That is what I see. (8/2/12)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
TSRD = strong hands on deck and only going north. Locking up more of the float every day.
This is 2 days in a row of volume well above 10 day avg. Yesterday they had an update on their upcoming acquisition that is on pinksheets.com. It was a follow up to Feb 5th news. All I see looks really good here. Current on pinksheets with a pretty nice S/S that is recent.
Super, this one is just getting warmed up with everything they have going on and coming down the line. Float is getting eaten up in a hurry.
Arch, I know you are serious and that excites me man. Looking forward to a big Friday.
TSRD....tick...tick....tick.....KABOOM!!!!!!!
19s up. Float drying fast.
TSRD is climbing nicely. Like what I am seeing here.
TSRD getting thinner the higher it goes.
TSRD has been a sleeping giant long enough. Needs to wake up all the way.
Nah, I would rather ride the beautiful TSRD to the bank.
TSRD only 84M float and updated yesterday about financing for an upcoming acquisition. Last couple days float has been getting eaten up. Looking very strong and steady for a major breakout.
Gotcha. I misunderstood ur post. Thought you were referring to TSRD. All good man. GOIG to da moon!!!!!!
TSRD strong. Feb 5th acquisition news. Follow up yesterday that financing is secure. Nowhere to go but up from here.
Please post information with your statement.
TSRD has multi-day multi bagger written all over it.
TSRD volume building again. 2 days in a row above 10day avg. Price always follows volume.
TSRD level 2 thin then. WOW, thanks az.
TSRD sure to be running well into tomorrow and possibly next week.
TSRD Level 2 screenshot anyone?
AZ! Man with each trader I see posting here, the more confident I feel about this one. NICE.
This thing being held in strong hands too. Not much wiggle room and starting to be less and less shares available.
Getting the financing is HUGE. That always leads to bigger and better things man.
I agree, Rain man. Float getting eaten up.
Harry, u do a great job on here keeping info available. TSRD is a beast in the making.
JTRC!!! Welcome aboard the TSRD money train. Good things in store hee.
Hey fozy. Good to see u here. I love what is going on with TSRD man.
Float getting eaten up the last couple of days. Gonna be really hard to get in when the acquisition is complete very soon.
TSRD continues to get strong volume. Float is drying up and when the acquisition news hits any day this one is gonna fly.
TSRD float getting eaten up last 2 days. Something really big coming. Breakout is imminent.
Excellent volume and movement here the last couple of days. Nice steady build up. Float getting eaten up little by little. Gonna be a tough get when the next news hits and this takes off.
Dude, Pink, you are on fire lately with your calls. Nice. Ready for the next one man.
Dude...incredible. PLTGQ blowing up!
Wow, I nailed this. :)
AENP potential sale of subsidiary:
Mar 04, 2010 08:30 ET
American Energy Production Inc. Announces Potential Sale of Subsidiary
MINERAL WELLS, TX--(Marketwire - March 4, 2010) - American Energy Production Inc. (OTCBB: AENP) announced today that it has signed a term sheet with a Calgary energy company Emerald Bay Energy Inc. and a private concern to buy its wholly owned subsidiary Production Resources Inc. The two entities will pay a combination of Emerald Bay Energy stock and cash for a total of $850,000.00 US. The sale will include all of the PRI lease acreage and equipment.
American Energy Production Inc. will retain a 1% overriding royalty on any oil or natural gas found below 1200 feet deep.
Charles Bitters, President of American Energy Production Inc., stated, "AENP decided to sale the PRI property and equipment to concentrate on its other oil and natural gas operations in North Texas and also to develop the Gold property in California."
More information on the sale will be forthcoming in the next few days.
Statements contained in this release, which are not historical facts, may be considered "forward-looking statements" and are based on current expectations and the current economic environment. We caution the reader that such forward-looking statements are not guarantees of future performance. Unknown risk, uncertainties, as well as other uncontrollable or unknown factors could cause actual results to materially differ from the result, performance, or expectations expressed or implied by such forward-looking statements.
KKUR news:
Mar 04, 2010 08:30 ET
ChromoCure Gains More Industry Support as Its Technology Shown Superior to 'Biomarkers': Biomarker Assays Diagnostics "Not Produced Hoped-For Results"
RENO, NV--(Marketwire - March 4, 2010) - ChromoCure, Inc. (PINKSHEETS: KKUR) -- ChromoCure's role in Cancer Detection and Research received more support from a report of the Cambridge Healthtech Institute's (CHI) "Biomarker Assay Development" conference held in late January in San Diego.
As reported in the March issue of Genetic Engineering & Biotechnology News (Vol. 30, No. 5): "pathway biomarkers have not produced hoped-for results in predicting patients' tumor sensitivity to targeted therapy"... and "[the] technologies also have not lived up to expectations."
Research has conclusively and irrefutably demonstrated aneuploidy as a more accurate predictor of cancer than cytological/histological analysis or genetic marker-based diagnostics that are the only other methods in existence today. ChromoCure's systems measure aneuploidy as the sole means of detecting cancer presence and measuring cancer progression. The system has a 100% effective accuracy rate.
Biomarkers, when supposedly 'effective,' detect either specific proteins generated by cancer, or a genetic anomaly. BOTH of these effects are products of aneuploidy and BOTH effects are transient due to the evolutionary, ever-changing aspect of aneuploidy. The correlation of 'markers' to the presence of cancer is an effect of the ever-changing chromosomal structures. That's why 'biomarker' approaches are not reliably effective and eventually become completely ineffective. Also of note: the transitional nature of chromosomal imbalance is the reason cancer eventually becomes 'immune' to chemotherapy. The drug targets a certain type of cell configuration. That configuration is momentary in the progression of aneuploidy (cancer). The configuration is also only a PORTION of the population of cells with aneuploidy. Detection of specific aspects of the cancer population is inaccurate and not reliable, as so much was admitted at the CHI conference. Therefore, detection of aneuploidy is 100% effective. It is this unique aspect of cancer present at all stages and in all cancers that is detected by the company's systems.
The Company's proprietary Chromosomal Scanner systems have proven accurate and efficient in the measurement of the unique genomic characteristic found in 100% of all cancers and never found in normal cells. The Company's detection technology has been proven to have an effective accuracy of 100% for all cancers at all stages. This is superior to biomarker detection in every measurable way. The Company recently published its collaborative clinical testing with a major cancer clinic.
The Company's focus on cancer research is further underscored by recent major clinical publications that both validate ChromoCure's chromosomal/aneuploidy theory of cancer and establish the company's detection approach as the forefront of both cancer detection and research.
The company's technology and related research opens the way for non-invasive and non-toxic solutions to cancer therapeutics and disease eradication. ChromoCure's scanner technologies include proprietary designs, processes, and algorithms centered on chromosomal imbalance. They provide the foundation for significant advantages in delivering important results in diagnosis, therapy and cure.
The Company invites industry and scientific collaboration through its "Project Boveri: Find the Cure" initiative.
Yeah I watched that one yesterday go ballistic. Be interesting to see it today for sure.
Looking for more today from TSRD.
Also watching:
DKSC
PLTGQ
NSTLQ
Thursday watchlist:
TSRD
NSTLQ
PLTGQ
CYNS
DKSC
2 Q plays I am watching closely today:
NSTLQ
PLTGQ